[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.194.190. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

August 2019 - April 2016

Decade

Year

Issue

October 2017, Vol 2, No. 10, Pages 1055-1170

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1055. doi:10.1001/jamacardio.2016.3669
Original Investigation

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Abstract Full Text
open access
JAMA Cardiol. 2017;2(10):1069-1078. doi:10.1001/jamacardio.2017.2762

This study evaluates the cost-effectiveness of evolocumab in patients with atherosclerotic cardiovascular disease when added to standard background therapy.

Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1079-1088. doi:10.1001/jamacardio.2017.2895

This systematic review and meta-analysis compares the long-term safety of coronary artery bypass grafting with that of percutaneous coronary intervention in patients with left main coronary artery stenosis.

Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1090-1099. doi:10.1001/jamacardio.2017.2945

This cohort study assesses agreement between thermodilution and estimated Fick cardiac output and compares how well these methods predict mortality.

Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1100-1107. doi:10.1001/jamacardio.2017.2471

This head-to-head comparative study evaluates the diagnostic accuracy of coronary computed tomography angiography, single-photon emission tomography, and positron emission tomography and explores the incremental value of hybrid imaging compared with fractional flow reserve.

Association of Neighborhood Demographics With Out-of-Hospital Cardiac Arrest Treatment and Outcomes: Where You Live May Matter

Abstract Full Text
free access has multimedia has audio
JAMA Cardiol. 2017;2(10):1110-1118. doi:10.1001/jamacardio.2017.2671

This cohort study examines whether resuscitation care and outcomes vary by the racial composition of the neighborhoods where out-of-hospital cardiac arrests occur.

Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study

Abstract Full Text
open access
JAMA Cardiol. 2017;2(10):1120-1127. doi:10.1001/jamacardio.2017.3180

This study aims to quantify the incidence of atrial fibrillation in patients at high risk for but without previously known atrial fibrillation using an insertable cardiac monitor.

Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1130-1139. doi:10.1001/jamacardio.2017.2976

This meta-analysis clarifies the role of secondary mitral regurgitation in the outcomes of patients with ischemic or idiopathic cardiomyopathies.

Brief Report

Association of Guideline Adherence for Serial Evaluations With Survival and Adverse Clinical Events in Patients With Asymptomatic Severe Aortic Stenosis

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1141-1146. doi:10.1001/jamacardio.2017.2952

This cohort study examines electronic medical records for adherence to close monitoring guidelines among patients with asymptomatic severe aortic stenosis.

Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical Myectomy

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1147-1151. doi:10.1001/jamacardio.2017.2353

This case series examines a series of patients diagnosed with hypertrophic cardiomyopathy and severe basal left ventricular outflow tract obstruction undergoing myectomy in whom the diagnosis of Anderson-Fabry cardiomyopathy was suspected by the cardiac surgeon intraoperatively and confirmed by histological and genetic examinations.

Research Letter

Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1164-1166. doi:10.1001/jamacardio.2017.3051

This study examines PCSK9i cost-sharing requirements for Medicare Part D plans nationwide, which insure 41 million beneficiaries.

Viewpoint

Incentivizing Transradial Access for Primary Percutaneous Coronary Intervention While Maintaining Timely Reperfusion

Abstract Full Text
JAMA Cardiol. 2017;2(10):1057-1058. doi:10.1001/jamacardio.2017.2348

This Viewpoint discusses a proposal to incentivize adopting transradial rather than transfemoral access for primary percutaneous coronary intervention to improve processes of care in patients with ST-segment elevation myocardial infarction.

Balanced Adoption of Radial Artery Access for Primary Percutaneous Coronary Intervention

Abstract Full Text
JAMA Cardiol. 2017;2(10):1059-1060. doi:10.1001/jamacardio.2017.2346

This Viewpoint discusses the need for determining an optimal balance between femoral and radial artery access in primary percutaneous coronary intervention.

What Is the Optimal Revascularization Strategy for Left Main Coronary Stenosis?

Abstract Full Text
JAMA Cardiol. 2017;2(10):1061-1062. doi:10.1001/jamacardio.2017.2946

This Viewpoint discusses various randomized clinical trials evaluating optimal treatment options, including coronary artery bypass grafting and percutaneous coronary intervention, for patients with left main coronary stenosis.

Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors

Abstract Full Text
JAMA Cardiol. 2017;2(10):1063-1064. doi:10.1001/jamacardio.2017.2959

This Viewpoint promotes using outcomes-based pricing strategies for proprotein convertase subtilisin/kexin type 9 inhibitors.

From the Heart

The Big Bang

Abstract Full Text
JAMA Cardiol. 2017;2(10):1065. doi:10.1001/jamacardio.2017.1738
Editorial

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy—Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value

Abstract Full Text
JAMA Cardiol. 2017;2(10):1066-1068. doi:10.1001/jamacardio.2017.2911
Invited Commentary

SPECT, PET, and CTA—Acronyms or Better Imaging?

Abstract Full Text
JAMA Cardiol. 2017;2(10):1108-1109. doi:10.1001/jamacardio.2017.2588

Neighborhood-Level Disparities in Resuscitation and the Potential of Connected Health

Abstract Full Text
JAMA Cardiol. 2017;2(10):1118-1119. doi:10.1001/jamacardio.2017.2763

What Do Implanted Cardiac Monitors Reveal About Atrial Fibrillation?

Abstract Full Text
JAMA Cardiol. 2017;2(10):1128-1129. doi:10.1001/jamacardio.2017.3203
Review

Role of Genetic Testing in Inherited Cardiovascular Disease: A Review

Abstract Full Text
has active quiz
JAMA Cardiol. 2017;2(10):1153-1160. doi:10.1001/jamacardio.2017.2352

This review provides an overview of the role of genetic testing for inherited cardiovascular disease among at-risk patients and their relatives, with considerations to successfully integrate genetic testing into clinical practice.

JAMA Cardiology Clinical Challenge

An Elderly Man With a Pacemaker and a Recent Fall

Abstract Full Text
has active quiz
JAMA Cardiol. 2017;2(10):1161-1162. doi:10.1001/jamacardio.2017.1932

A man in his 80s with a pacemaker presents to the emergency department after falling in his bathroom; there was no associated loss of consciousness, chest pain, dyspnea, or palpitations. What would you do next?

Comment & Response

Increased Cardiovascular Risk Associated With E-Cigarette Use

Abstract Full Text
JAMA Cardiol. 2017;2(10):1166. doi:10.1001/jamacardio.2017.1692

Increased Cardiovascular Risk Associated With E-Cigarette Use—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(10):1166-1167. doi:10.1001/jamacardio.2017.1766

Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants

Abstract Full Text
JAMA Cardiol. 2017;2(10):1167. doi:10.1001/jamacardio.2017.2031

Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(10):1168. doi:10.1001/jamacardio.2017.2034

PCSK9 Inhibitors, Statins, Low-Density Lipoprotein Cholesterol, Mevalonate Pathway, and Toxicity

Abstract Full Text
JAMA Cardiol. 2017;2(10):1168-1169. doi:10.1001/jamacardio.2017.2727

Identifying Genotypes and Phenotypes of Cardiovascular Diseases Using Big Data Analytics

Abstract Full Text
JAMA Cardiol. 2017;2(10):1169-1170. doi:10.1001/jamacardio.2017.1857

PCSK9 Inhibitors, Statins, Low-Density Lipoprotein Cholesterol, Mevalonate Pathway, and Toxicity—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(10):1169. doi:10.1001/jamacardio.2017.2734
Editor's Note

Left Main Revascularization in 2017: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?

Abstract Full Text
JAMA Cardiol. 2017;2(10):1089. doi:10.1001/jamacardio.2017.3154

Secondary Mitral Regurgitation and Survival in Patients With Left Ventricular Dysfunction

Abstract Full Text
JAMA Cardiol. 2017;2(10):1139-1140. doi:10.1001/jamacardio.2017.3038

Incorporating Genetic Testing Into Cardiovascular Practice

Abstract Full Text
JAMA Cardiol. 2017;2(10):1151-1152. doi:10.1001/jamacardio.2017.2626
Correction

Error in Figure

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1170. doi:10.1001/jamacardio.2017.3817
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2017;2(10):1056. doi:10.1001/jamacardio.2016.3670
×